Metastatic triple-negative breast cancer treatment failed to meet PFS primary endpoint
News
Dupixent trial meets endpoints for childhood eczema
Sanofi/Regeneron biologic offers alternative to topical steroids
GSK, SK to compare COVID-19 vaccine candidate to AZ’s jab
Phase III trial will use AZ’s COVID-19 vaccine as an active comparator
MHRA authorises UCB’s Bimzelx via post-Brexit licensing pathway
The MHRA decision closely follows a recent positive recommendation from NICE
EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
Accelerated assessment granted for company’s lead product candidate ganaxolone
ICR cancer drug NXP800 to enter Phase I trials
The investigational drug targets the HSF1 pathway
NICE ‘no’ for Janssen’s Darzalex combo
Draft guidance shows concerns on cost-effectiveness of treatment
Existing drug could offer hope as new therapy for ALL in children
Early stage research found 5-azacytidine may be used to treat ‘devastating’ disease
Cara, Vifor receive FDA nod for pruritus treatment
Korsuva injection will treat CKD patients undergoing haemodialysis
MSD’s pneumococcal vaccine hits ‘key endpoints’ in Phase III
Phase III trial evaluated use in infants 42-90 days old
Home antibody tests for COVID-19 to be made available in UK
Up to 8,000 people per day can access the tests
EU approval for Rinvoq to treat atopic dermatitis
Positive Phase III results for Abbvie’s oral JAK inhibitor
UK study to test third COVID-19 vaccine for immunocompromised
Participants will be given Pfizer, Moderna or Novavax vaccines
NHS to roll out same-day pre-eclampsia test for pregnant women
New blood test rules out life-threatening condition
Study finds protection against COVID-19 ‘waning’ in fully vaccinated people
The ZOE COVID Study app assessed data on positive COVID-19 PCR test results between May and July 2021
